TAZ Promotes PC2 Degradation through a SCFβ-Trcp E3 Ligase Complex

ABSTRACT Studies of a TAZ knockout mouse reveal a novel function of the transcriptional regulator TAZ, that is, as a binding partner of the F-box protein β-Trcp. TAZ−/− mice develop polycystic kidney disease (PKD) and emphysema. The calcium-permeable cation channel protein polycystin 2 (PC2) is overexpressed in kidneys of TAZ−/− mice as a result of decreased degradation via an SCFβ-Trcp E3 ubiquitin ligase pathway. Replacements of serines in a phosphodegron motif in TAZ prevent β-Trcp binding and PC2 degradation. Coexpression of a cytoplasmic fragment of polycystin 1 blocks the PC2-TAZ interaction and prevents TAZ-mediated degradation of PC2. Depletion of TAZ in zebrafish also results in a cystic kidney accompanied by overexpression of PC2. These results establish a common role of TAZ across vertebrate species in a protein degradation pathway regulated by phosphorylation and implicate deficiencies in this pathway in the development of PKD.

[1]  J. Calvet,et al.  A hereditary model of slowly progressive polycystic kidney disease in the mouse. , 1991, Journal of the American Society of Nephrology : JASN.

[2]  Alessandra Boletta,et al.  PKD1 Induces p21waf1 and Regulation of the Cell Cycle via Direct Activation of the JAK-STAT Signaling Pathway in a Process Requiring PKD2 , 2002, Cell.

[3]  P. D’Eustachio,et al.  Evidence that two phenotypically distinct mouse PKD mutations, bpk and jcpk, are allelic. , 1996, Kidney international.

[4]  Family , 2006 .

[5]  J. Sharpe,et al.  A human PKD1 transgene generates functional polycystin-1 in mice and is associated with a cystic phenotype. , 2000, Human molecular genetics.

[6]  Michele Pagano,et al.  SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27 , 1999, Nature Cell Biology.

[7]  A. Lund,et al.  RUNX: a trilogy of cancer genes. , 2002, Cancer cell.

[8]  E. Olson,et al.  A WW domain protein TAZ is a critical coactivator for TBX5, a transcription factor implicated in Holt-Oram syndrome. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[9]  L. Guay-Woodford.  Murine models of polycystic kidney disease: molecular and therapeutic insights. , 2003, American journal of physiology. Renal physiology.

[10]  H. Cantiello,et al.  Polycystin-2, the protein mutated in autosomal dominant polycystic kidney disease (ADPKD), is a Ca2+-permeable nonselective cation channel , 2001 .

[11]  Stephen J. Elledge,et al.  SKP1 Connects Cell Cycle Regulators to the Ubiquitin Proteolysis Machinery through a Novel Motif, the F-Box , 1996, Cell.

[12]  L. Satlin,et al.  Developmental expression of ROMK in rat kidney. , 1999, American journal of physiology. Renal physiology.

[13]  M. Yaffe,et al.  TAZ: a novel transcriptional co‐activator regulated by interactions with 14‐3‐3 and PDZ domain proteins , 2000, The EMBO journal.

[14]  Jing Zhou,et al.  Constitutive Activation of G-proteins by Polycystin-1 Is Antagonized by Polycystin-2* , 2002, The Journal of Biological Chemistry.

[15]  J. Hughes,et al.  The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains , 1995, Nature Genetics.

[16]  M. Scheffner,et al.  Localization of the E6-AP regions that direct human papillomavirus E6 binding, association with p53, and ubiquitination of associated proteins , 1993, Molecular and cellular biology.

[17]  Martijn H Breuning,et al.  Lowering of Pkd1 expression is sufficient to cause polycystic kidney disease. , 2004, Human molecular genetics.

[18]  G. Pazour,et al.  Chlamydomonas IFT88 and Its Mouse Homologue, Polycystic Kidney Disease Gene Tg737, Are Required for Assembly of Cilia and Flagella , 2000, The Journal of cell biology.

[19]  G. Germino,et al.  Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents , 2000, Nature.

[20]  Michele Pagano,et al.  Degradation of Cdc25A by β-TrCP during S phase and in response to DNA damage , 2003, Nature.

[21]  G. Germino,et al.  PKD1 interacts with PKD2 through a probable coiled-coil domain , 1997, Nature Genetics.

[22]  P. S. St George-Hyslop,et al.  Somatic PKD2 mutations in individual kidney and liver cysts support a "two-hit" model of cystogenesis in type 2 autosomal dominant polycystic kidney disease. , 1999, Journal of the American Society of Nephrology : JASN.

[23]  Mark S. Miller,et al.  A genetic screen in zebrafish identifies cilia genes as a principal cause of cystic kidney , 2004, Development.

[24]  P. Igarashi,et al.  A minimal Ksp-cadherin promoter linked to a green fluorescent protein reporter gene exhibits tissue-specific expression in the developing kidney and genitourinary tract. , 2002, Journal of the American Society of Nephrology : JASN.

[25]  H. Cantiello,et al.  Polycystin-2, the protein mutated in autosomal dominant polycystic kidney disease (ADPKD), is a Ca2+-permeable nonselective cation channel. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[26]  S. Itohara,et al.  Causal Relationship between the Loss of RUNX3 Expression and Gastric Cancer , 2002, Cell.

[27]  R F Standaert,et al.  Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin , 1995, Science.

[28]  P. Koulen,et al.  Polycystin-2 accelerates Ca2+ release from intracellular stores in Caenorhabditis elegans. , 2005, Cell calcium.

[29]  P. Gabow,et al.  Linkage heterogeneity of autosomal dominant polycystic kidney disease. , 1988, The New England journal of medicine.

[30]  Jing Zhou,et al.  Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells , 2003, Nature Genetics.

[31]  L. Dick,et al.  Mechanistic Studies on the Inactivation of the Proteasome by Lactacystin , 1996, The Journal of Biological Chemistry.

[32]  A. Amsterdam,et al.  A large-scale insertional mutagenesis screen in zebrafish. , 1999, Genes & development.

[33]  L. Flaherty,et al.  New mouse model for polycystic kidney disease with both recessive and dominant gene effects. , 1995, Kidney international.

[34]  Thomas Benjamin,et al.  TAZ, a Transcriptional Modulator of Mesenchymal Stem Cell Differentiation , 2005, Science.

[35]  W. E. Koch,et al.  A genetically determined murine model of infantile polycystic kidney disease. , 1985, The Journal of urology.

[36]  R. Kucherlapati,et al.  Somatic Inactivation of Pkd2 Results in Polycystic Kidney Disease , 1998, Cell.

[37]  T. Kitamura,et al.  Plat-E: an efficient and stable system for transient packaging of retroviruses , 2000, Gene Therapy.

[38]  Stephen J. Elledge,et al.  The SCFβ-TRCP–ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IκBα and β-catenin and stimulates IκBα ubiquitination in vitro , 1999 .

[39]  Y. Uchijima,et al.  Transcriptional activity of Pax3 is co-activated by TAZ. , 2006, Biochemical and biophysical research communications.

[40]  G. Karsenty,et al.  Transcriptional Coactivation of Bone-Specific Transcription Factor Cbfa1 by TAZ , 2003, Molecular and Cellular Biology.

[41]  Dawei Li,et al.  Identification of TAZ as a Binding Partner of the Polyomavirus T Antigens , 2004, Journal of Virology.

[42]  The Angelman Syndrome-Associated Protein, E6-AP, Is a Coactivator for the Nuclear Hormone Receptor Superfamily , 1999, Molecular and Cellular Biology.

[43]  S. Somlo,et al.  Polycystin-2 is an intracellular calcium release channel , 2002, Nature Cell Biology.

[44]  Y. Ito,et al.  Comparison of the human genomic structure of the Runt domain-encoding PEBP2/CBFalpha gene family. , 1996, Gene.

[45]  Y. Ito.  [Signals and transcription factors]. , 1989, Gan to kagaku ryoho. Cancer & chemotherapy.

[46]  M. Yaffe,et al.  The transcriptional co-activator TAZ interacts differentially with transcriptional enhancer factor-1 (TEF-1) family members. , 2005, The Biochemical journal.

[47]  S. Reeders.  Multilocus polycystic disease , 1992, Nature Genetics.

[48]  E. Brown,et al.  Polycystin-2 is a novel cation channel implicated in defective intracellular Ca(2+) homeostasis in polycystic kidney disease. , 2001, Biochemical and biophysical research communications.

[49]  M. Yaffe,et al.  TAZ Interacts with TTF-1 and Regulates Expression of Surfactant Protein-C* , 2004, Journal of Biological Chemistry.

[50]  L. Sandkuijl,et al.  Genetic heterogeneity of polycystic kidney disease in Europe. , 1992, Contributions to nephrology.

[51]  Y. Ito,et al.  Loss of responsiveness of an AP1-related factor, PEBP1, to 12-O-tetradecanoylphorbol-13-acetate after transformation of NIH 3T3 cells by the Ha-ras oncogene , 1989, Journal of Virology.

[52]  G. Germino,et al.  The Molecular Basis of Focal Cyst Formation in Human Autosomal Dominant Polycystic Kidney Disease Type I , 1996, Cell.

[53]  M. Scheffner,et al.  A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. , 1991, The EMBO journal.

[54]  H. Ko,et al.  Glomerulocystic kidney disease in mice with a targeted inactivation of Wwtr1 , 2007, Proceedings of the National Academy of Sciences.

[55]  S. Somlo,et al.  Molecular genetics and mechanism of autosomal dominant polycystic kidney disease. , 2000, Molecular genetics and metabolism.

[56]  Hong Sun,et al.  p27Kip1 ubiquitination and degradation is regulated by the SCFSkp2 complex through phosphorylated Thr187 in p27 , 1999, Current Biology.

[57]  E. Winocour.  Purification of polyoma virus. , 1963, Virology.

[58]  S. Nauli,et al.  Gating of the polycystin ion channel signaling complex in neurons and kidney cells , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[59]  J. Calvet.  Cilia in PKD--letting it all hang out. , 2002, Journal of the American Society of Nephrology : JASN.

[60]  James P Calvet,et al.  Polycystin-1 Activation of c-Jun N-terminal Kinase and AP-1 Is Mediated by Heterotrimeric G Proteins* , 2002, The Journal of Biological Chemistry.

[61]  V. Sukhatme,et al.  Homo- and heterodimeric interactions between the gene products of PKD1 and PKD2. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[62]  A. Schier,et al.  Early development of the zebrafish pronephros and analysis of mutations affecting pronephric function. , 1998, Development.

[63]  Patricia A. Gabow,et al.  PKD2, a Gene for Polycystic Kidney Disease That Encodes an Integral Membrane Protein , 1996, Science.

[64]  Jing Zhou,et al.  Polycystins and mechanosensation in renal and nodal cilia , 2004, BioEssays : news and reviews in molecular, cellular and developmental biology.

[65]  L. Guay-Woodford,et al.  The polycystic kidney disease proteins, polycystin-1, polycystin-2, polaris, and cystin, are co-localized in renal cilia. , 2002, Journal of the American Society of Nephrology : JASN.

[66]  Jun Qin,et al.  SCFbeta-TRCP links Chk1 signaling to degradation of the Cdc25A protein phosphatase. , 2003, Genes & development.

[67]  S. Somlo,et al.  Calcium Dependence of Polycystin-2 Channel Activity Is Modulated by Phosphorylation at Ser812* , 2004, Journal of Biological Chemistry.

[68]  W. E. Koch,et al.  Murine congenital polycystic kidney disease: a model for studying development of cystic disease. , 1982, The Journal of urology.

[69]  Jing Zhou,et al.  Native Polycystin 2 Functions as a Plasma Membrane Ca2+-Permeable Cation Channel in Renal Epithelia , 2003, Molecular and Cellular Biology.

[70]  P. Bork,et al.  Polycystic kidney disease: The complete structure of the PKD1 gene and its protein , 1995, Cell.